Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy

A retrospective study was performed to assess the outcome of patients with diffuse large B cell lymphoma (DLBCL) who did not achieve complete response or who relapsed before and after the use of rituximab. Clinical features and outcome of 816 (425 M/391 F; median age 63 years) patients diagnosed fro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Hematol
Asıl Yazarlar: Rovira, Jordina, Valera, Alexandra, Colomo, Lluis, Setoain, Xavier, Rodríguez, Sonia, Martínez-Trillos, Alejandra, Giné, Eva, Dlouhy, Ivan, Magnano, Laura, Gaya, Anna, Martínez, Daniel, Martínez, Antonio, Campo, Elías, López-Guillermo, Armando
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2014
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4374121/
https://ncbi.nlm.nih.gov/pubmed/25501975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-014-2271-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller